Collateral Agrees to Be Purchased by Partner for $140M

Biotech: Analyst Positive About Deal; Stock Jumps

BY MARION WEBB
Senior Staff Writer

San Diego-based gene therapy company Collateral Therapeutics Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129